![PDF] Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5c2330a7e20affaf506ba421407aa70a9a225a24/5-Figure1-1.png "PDF] Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Semantic Scholar")
PDF] Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults | Semantic Scholar
Favorable aspects and potential difficulties foreseen by the EP with... | Download Scientific Diagram
Fostamatinib: A Review in Chronic Immune Thrombocytopenia | SpringerLink
Fostamatinib for persistent/chronic adult immune thrombocytopenia | Immunotherapy
Frontiers | Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
Mechanism of Action | TAVALISSE HCP
JCM | Free Full-Text | Primary Immune Thrombocytopenia: Novel Insights into Pathophysiology and Disease Management
Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion - Alessandro Lucchesi, Bruno Fattizzo, Valerio De Stefano, Marco Ruggeri, Sergio Siragusa, Nicola Vianelli, Francesco
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib - Nichola Cooper, Ivy Altomare, Mark R. Thomas, Phillip L. R. Nicolson, Steve P. Watson, Vadim Markovtsov, Leslie K. Todd,
Frontiers | Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?
JCM | Free Full-Text | Emerging Therapies in Immune Thrombocytopenia
Thrombopoietin receptor agonists: ten years later | Haematologica
Evolution of CLL treatment — from chemoimmunotherapy to targeted and individualized therapy | Nature Reviews Clinical Oncology
Autoimmune thrombocytopenia: Current treatment options in adults with a focus on novel drugs
APS Publications on Twitter: "Platelets and tyrosine kinase inhibitors: clinical features, mechanism of action and effects on physiology - new Review in @AJPCellPhys https://t.co/G9SSGG4Hrq #platelets #articlesinpress https://t.co/oJ0JnJMjho" / Twitter
Fostamatinib for persistent/chronic adult immune thrombocytopenia | Immunotherapy
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Mechanism of Action | TAVALISSE HCP
Recent advances in the mechanisms and treatment of immune thrombocytopenia - eBioMedicine
Rigel launches Phase II trial to assess fostamatinib for Covid-19
COVID-19 :: Rigel Pharmaceuticals, Inc. (RIGL)
Novel therapies for immune thrombocytopenia - Kuter - 2022 - British Journal of Haematology - Wiley Online Library
g176401moi008.gif
Medicina | Free Full-Text | Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms
Mechanism of Action | TAVALISSE HCP
